Department of Pediatric Anesthesiology and Intensive Care, Medical University of Warsaw University Clinical Centre, 63A Żwirki i Wigury St., 02-091, Warsaw, Poland.
Department of Modeling and Supporting of Internal Organs Functions, Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, 4 Trojdena St., 02-109, Warsaw, Poland.
Sci Rep. 2022 Aug 18;12(1):14038. doi: 10.1038/s41598-022-18243-3.
We assessed the influence of systemic lidocaine administration on ventilatory and circulatory parameters, and the pneumoperitoneum impact on the cardiopulmonary system during a laparoscopic appendectomy in children. A single-center parallel single-masked randomized controlled study was carried out with 58 patients (3-17 years). Intravenous lidocaine bolus of 1.5 mg/kg over 5 min before induction of anesthesia followed by lidocaine infusion at 1.5 mg/kg/h intraoperatively. Respiratory system compliance (C, C/kg), P-PEEP and Pulse rate (Pulse), systolic, diastolic and mean blood pressure (NBP, NBP, NBP), assessed in the Lidocaine and Control group, at the: beginning (P), minimum lung compliance (P) and at the end of surgery (P) were compared. The respiratory/hemodynamic parameters did not differ between the groups at any stage of operation. Blood Pressure and P-PEEP were significantly higher at the P compared to P and P stages (P < 0.001, 1 - β ≥ 0.895) that correlated with lung compliance changes: C/kg vs. NBP and P-PEEP (- 0.42, - 0.84; P < 0.001); C vs. Pulse and P-PEEP (- 0.48, - 0.46; P < 0.001). Although an increase in intraabdominal pressure up to 12(15) mmHg causes significant changes in hemodynamic/respiratory parameters, there appears to be no risk of fatal reactions in 1E, 2E ASA patients. Systemic lidocaine administration doesn't alleviate circulatory/respiratory alterations during pneumoperitoneum. No lidocaine related episode of anaphylaxis, systemic toxicity, circulatory disturbances or neurological impairment occurred.ClinicalTrials.gov: 22/03/2019.Trial registration number: NCT03886896.
我们评估了全身给予利多卡因对小儿腹腔镜阑尾切除术期间通气和循环参数的影响,以及气腹对心肺系统的影响。这是一项单中心平行单盲随机对照研究,纳入了 58 名患者(3-17 岁)。在麻醉诱导前 5 分钟内静脉注射 1.5mg/kg 利多卡因负荷量,然后在手术期间以 1.5mg/kg/h 的速度输注利多卡因。在利多卡因组和对照组中评估呼吸系统顺应性(C,C/kg)、P-PEEP 和脉搏率(Pulse)、收缩压、舒张压和平均血压(NBP,NBP,NBP),在以下时间点进行评估:麻醉诱导时(P)、最小肺顺应性(P)和手术结束时(P)。在手术的任何阶段,两组的呼吸/血流动力学参数均无差异。与肺顺应性变化相关的血压和 P-PEEP 在 P 阶段与 P 和 P 阶段相比显著升高(P<0.001,1-β≥0.895):C/kg 与 NBP 和 P-PEEP(-0.42,-0.84;P<0.001);C 与脉搏和 P-PEEP(-0.48,-0.46;P<0.001)。尽管腹腔内压力增加到 12(15)mmHg 会导致血流动力学/呼吸参数发生显著变化,但在 1E、2E ASA 患者中似乎没有致命反应的风险。全身给予利多卡因不能缓解气腹期间的循环/呼吸变化。未发生与利多卡因相关的过敏反应、全身毒性、循环障碍或神经损伤。ClinicalTrials.gov:2019 年 3 月 22 日。试验注册号:NCT03886896。